Table 3.
Procedural outcomes.
| No GP IIb/IIIa inhibitor used (n = 1753) | GP IIb/IIIa inhibitor used (n = 1294) | Significance (P) | |
|---|---|---|---|
| Inhospital | |||
| MACE | 24 (1.37%) | 22 (1.70%) | 0.457 |
| Death | 13 (0.74%) | 7 (0.54%) | 0.651 |
| Q wave MI | 5 (0.29%) | 12 (0.93%) | 0.025* |
| Reintervention PCI | 5 (0.29%) | 6 (0.46%) | 0.543 |
| Emergency CABG | 3 (0.17%) | 1 (0.08%) | 0.641 |
| Coronary dissection/perforation | 25 (1.43%) | 26 (2.01%) | 0.253 |
| CVA | 2 (0.11%) | 0 (0.00%) | 0.511 |
| Side branch occlusion | 10 (0.57%) | 9 (0.70%) | 0.817 |
| Major bleeding | 6 (0.34%) | 14 (1.08%) | 0.021* |
| Minor bleeding | 36 (2.05%) | 40 (3.09%) | 0.078 |
| Total bleeding | 42 (2.40%) | 54 (4.17%) | 0.0063* |
| Heart block requiring pacing | 2 (0.11%) | 1 (0.08%) | 0.578 |
| DC cardioversion | 4 (0.23%) | 2 (0.15%) | 1.00 |
*P value < 0.05.